Pomerantz LLP Investigates Claims Against Tesla Inc. and Other Companies

Pomerantz LLP is investigating claims on behalf of investors of the following companies:

Tesla Inc.

• July 26, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Tesla Inc. (NASDAQ: TSLA).
• August 15, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Tesla Inc. (NASDAQ: TSLA).
• April 24, 2021 - Pomerantz LLP is investigating claims on behalf of investors of Tesla Inc. (NASDAQ: TSLA).
• July 24, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Tesla Inc. (NASDAQ: TSLA).
• August 9, 2024 - The Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tesla Inc. (NASDAQ: TSLA)

Salesforce Inc.

• July 20, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Salesforce Inc. (NYSE: CRM).

Stellantis NV

• March 3, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Stellantis NV (NYSE: STLA).

Nano Nuclear

• August 5, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Nano Nuclear

Ford Motor

• August 5, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Ford Motor (NYSE: F).

BlackBerry Limited

• April 24, 2021 - Pomerantz LLP is investigating claims on behalf of investors of BlackBerry Limited (NYSE: BB).

Zoetis Inc.

• May 23, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (NYSE: ZTS).

Owens Minor Inc.

• July 26, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Owens Minor Inc. (NYSE: OMI).

Petco Health and Wellness Company Inc.

• Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health and Wellness Company Inc. (NASDAQ: WOOF).

The Chemours

• March 21, 2024 - Pomerantz LLP is investigating claims on behalf of investors of The Chemours (NYSE: CC).

Warner Bros.

• August 9, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Warner Bros. (NYSE: WBD).

Sage Therapeutics Inc.

• September 9, 2024 - Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics Inc. (NASDAQ: SAGE).